FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18448611000001103: Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Feb 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
63325101000001118 Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
63325201000001113 Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd) Is a Nilotinib 150mg capsules true Inferred relationship Existential restriction modifier
Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd) Has active ingredient Nilotinib true Inferred relationship Existential restriction modifier
Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient Nilotinib hydrochloride monohydrate true Inferred relationship Existential restriction modifier
Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Nilotinib true Inferred relationship Existential restriction modifier
Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd) Is a Tasigna true Inferred relationship Existential restriction modifier
Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd) Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd) Has basis of strength substance Nilotinib true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd) 112 capsule 4 x 28 capsules Has AMP True Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start